Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Disorders Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Therapy Market Perspective (2018-2029)
2.2 Retinal Disorders Therapy Growth Trends by Region
2.2.1 Global Retinal Disorders Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Retinal Disorders Therapy Historic Market Size by Region (2018-2024)
2.2.3 Retinal Disorders Therapy Forecasted Market Size by Region (2024-2029)
2.3 Retinal Disorders Therapy Market Dynamics
2.3.1 Retinal Disorders Therapy Industry Trends
2.3.2 Retinal Disorders Therapy Market Drivers
2.3.3 Retinal Disorders Therapy Market Challenges
2.3.4 Retinal Disorders Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorders Therapy Players by Revenue
3.1.1 Global Top Retinal Disorders Therapy Players by Revenue (2018-2024)
3.1.2 Global Retinal Disorders Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorders Therapy Revenue
3.4 Global Retinal Disorders Therapy Market Concentration Ratio
3.4.1 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Therapy Revenue in 2022
3.5 Retinal Disorders Therapy Key Players Head office and Area Served
3.6 Key Players Retinal Disorders Therapy Product Solution and Service
3.7 Date of Enter into Retinal Disorders Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Therapy Breakdown Data by Type
4.1 Global Retinal Disorders Therapy Historic Market Size by Type (2018-2024)
4.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2024-2029)
5 Retinal Disorders Therapy Breakdown Data by Application
5.1 Global Retinal Disorders Therapy Historic Market Size by Application (2018-2024)
5.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Retinal Disorders Therapy Market Size (2018-2029)
6.2 North America Retinal Disorders Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Retinal Disorders Therapy Market Size by Country (2018-2024)
6.4 North America Retinal Disorders Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size (2018-2029)
7.2 Europe Retinal Disorders Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Retinal Disorders Therapy Market Size by Country (2018-2024)
7.4 Europe Retinal Disorders Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Therapy Market Size (2018-2029)
8.2 Asia-Pacific Retinal Disorders Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Retinal Disorders Therapy Market Size (2018-2029)
9.2 Latin America Retinal Disorders Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Retinal Disorders Therapy Market Size by Country (2018-2024)
9.4 Latin America Retinal Disorders Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Therapy Market Size (2018-2029)
10.2 Middle East & Africa Retinal Disorders Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Detail
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Retinal Disorders Therapy Introduction
11.1.4 ALLERGAN Revenue in Retinal Disorders Therapy Business (2018-2024)
11.1.5 ALLERGAN Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Detail
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Retinal Disorders Therapy Introduction
11.2.4 AbbVie Revenue in Retinal Disorders Therapy Business (2018-2024)
11.2.5 AbbVie Recent Development
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Detail
11.3.2 Alimera Sciences Business Overview
11.3.3 Alimera Sciences Retinal Disorders Therapy Introduction
11.3.4 Alimera Sciences Revenue in Retinal Disorders Therapy Business (2018-2024)
11.3.5 Alimera Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Retinal Disorders Therapy Introduction
11.4.4 Janssen Biotech Revenue in Retinal Disorders Therapy Business (2018-2024)
11.4.5 Janssen Biotech Recent Development
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Detail
11.5.2 Swedish Orphan Biovitrum Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Introduction
11.5.4 Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2018-2024)
11.5.5 Swedish Orphan Biovitrum Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Retinal Disorders Therapy Introduction
11.6.4 Roche Revenue in Retinal Disorders Therapy Business (2018-2024)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2018-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Genzyme
11.8.1 Genzyme Company Detail
11.8.2 Genzyme Business Overview
11.8.3 Genzyme Retinal Disorders Therapy Introduction
11.8.4 Genzyme Revenue in Retinal Disorders Therapy Business (2018-2024)
11.8.5 Genzyme Recent Development
11.9 Genentech
11.9.1 Genentech Company Detail
11.9.2 Genentech Business Overview
11.9.3 Genentech Retinal Disorders Therapy Introduction
11.9.4 Genentech Revenue in Retinal Disorders Therapy Business (2018-2024)
11.9.5 Genentech Recent Development
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Detail
11.10.2 OCULAR THERAPEUTIX Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Introduction
11.10.4 OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2018-2024)
11.10.5 OCULAR THERAPEUTIX Recent Development
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Detail
11.11.2 Bausch & Lomb Business Overview
11.11.3 Bausch & Lomb Retinal Disorders Therapy Introduction
11.11.4 Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2018-2024)
11.11.5 Bausch & Lomb Recent Development
11.12 UCBCares
11.12.1 UCBCares Company Detail
11.12.2 UCBCares Business Overview
11.12.3 UCBCares Retinal Disorders Therapy Introduction
11.12.4 UCBCares Revenue in Retinal Disorders Therapy Business (2018-2024)
11.12.5 UCBCares Recent Development
11.13 Aier Eye Hospital
11.13.1 Aier Eye Hospital Company Detail
11.13.2 Aier Eye Hospital Business Overview
11.13.3 Aier Eye Hospital Retinal Disorders Therapy Introduction
11.13.4 Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024)
11.13.5 Aier Eye Hospital Recent Development
11.14 Alcon Holdings, Inc.
11.14.1 Alcon Holdings, Inc. Company Detail
11.14.2 Alcon Holdings, Inc. Business Overview
11.14.3 Alcon Holdings, Inc. Retinal Disorders Therapy Introduction
11.14.4 Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2018-2024)
11.14.5 Alcon Holdings, Inc. Recent Development
11.15 Eyebright Medical
11.15.1 Eyebright Medical Company Detail
11.15.2 Eyebright Medical Business Overview
11.15.3 Eyebright Medical Retinal Disorders Therapy Introduction
11.15.4 Eyebright Medical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.15.5 Eyebright Medical Recent Development
11.16 Kanghong Pharmaceutical
11.16.1 Kanghong Pharmaceutical Company Detail
11.16.2 Kanghong Pharmaceutical Business Overview
11.16.3 Kanghong Pharmaceutical Retinal Disorders Therapy Introduction
11.16.4 Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.16.5 Kanghong Pharmaceutical Recent Development
11.17 Huaxia Eye Hospital
11.17.1 Huaxia Eye Hospital Company Detail
11.17.2 Huaxia Eye Hospital Business Overview
11.17.3 Huaxia Eye Hospital Retinal Disorders Therapy Introduction
11.17.4 Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024)
11.17.5 Huaxia Eye Hospital Recent Development
11.18 Xingqi Pharmaceutical
11.18.1 Xingqi Pharmaceutical Company Detail
11.18.2 Xingqi Pharmaceutical Business Overview
11.18.3 Xingqi Pharmaceutical Retinal Disorders Therapy Introduction
11.18.4 Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024)
11.18.5 Xingqi Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Retinal Disorders Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Age Related Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Ocular Inflammatory Disease (Uveitis)
Table 5. Key Players of Macular Hole
Table 6. Global Retinal Disorders Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Retinal Disorders Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Retinal Disorders Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Retinal Disorders Therapy Market Share by Region (2018-2024)
Table 10. Global Retinal Disorders Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Retinal Disorders Therapy Market Share by Region (2024-2029)
Table 12. Retinal Disorders Therapy Market Trends
Table 13. Retinal Disorders Therapy Market Drivers
Table 14. Retinal Disorders Therapy Market Challenges
Table 15. Retinal Disorders Therapy Market Restraints
Table 16. Global Retinal Disorders Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Retinal Disorders Therapy Market Share by Players (2018-2024)
Table 18. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2022)
Table 19. Ranking of Global Top Retinal Disorders Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Retinal Disorders Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorders Therapy Product Solution and Service
Table 23. Date of Enter into Retinal Disorders Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorders Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Retinal Disorders Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Retinal Disorders Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Retinal Disorders Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Retinal Disorders Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Retinal Disorders Therapy Revenue Market Share by Application (2018-2024)
Table 31. Global Retinal Disorders Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Retinal Disorders Therapy Revenue Market Share by Application (2024-2029)
Table 33. North America Retinal Disorders Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Retinal Disorders Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Retinal Disorders Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Retinal Disorders Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Retinal Disorders Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Retinal Disorders Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Retinal Disorders Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Retinal Disorders Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Retinal Disorders Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. ALLERGAN Company Detail
Table 49. ALLERGAN Business Overview
Table 50. ALLERGAN Retinal Disorders Therapy Product
Table 51. ALLERGAN Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 52. ALLERGAN Recent Development
Table 53. AbbVie Company Detail
Table 54. AbbVie Business Overview
Table 55. AbbVie Retinal Disorders Therapy Product
Table 56. AbbVie Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 57. AbbVie Recent Development
Table 58. Alimera Sciences Company Detail
Table 59. Alimera Sciences Business Overview
Table 60. Alimera Sciences Retinal Disorders Therapy Product
Table 61. Alimera Sciences Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 62. Alimera Sciences Recent Development
Table 63. Janssen Biotech Company Detail
Table 64. Janssen Biotech Business Overview
Table 65. Janssen Biotech Retinal Disorders Therapy Product
Table 66. Janssen Biotech Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 67. Janssen Biotech Recent Development
Table 68. Swedish Orphan Biovitrum Company Detail
Table 69. Swedish Orphan Biovitrum Business Overview
Table 70. Swedish Orphan Biovitrum Retinal Disorders Therapy Product
Table 71. Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 72. Swedish Orphan Biovitrum Recent Development
Table 73. Roche Company Detail
Table 74. Roche Business Overview
Table 75. Roche Retinal Disorders Therapy Product
Table 76. Roche Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Bristol-Myers Squibb Company Detail
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Retinal Disorders Therapy Product
Table 81. Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Genzyme Company Detail
Table 84. Genzyme Business Overview
Table 85. Genzyme Retinal Disorders Therapy Product
Table 86. Genzyme Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 87. Genzyme Recent Development
Table 88. Genentech Company Detail
Table 89. Genentech Business Overview
Table 90. Genentech Retinal Disorders Therapy Product
Table 91. Genentech Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. OCULAR THERAPEUTIX Company Detail
Table 94. OCULAR THERAPEUTIX Business Overview
Table 95. OCULAR THERAPEUTIX Retinal Disorders Therapy Product
Table 96. OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 97. OCULAR THERAPEUTIX Recent Development
Table 98. Bausch & Lomb Company Detail
Table 99. Bausch & Lomb Business Overview
Table 100. Bausch & Lomb Retinal Disorders Therapy Product
Table 101. Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 102. Bausch & Lomb Recent Development
Table 103. UCBCares Company Detail
Table 104. UCBCares Business Overview
Table 105. UCBCares Retinal Disorders Therapy Product
Table 106. UCBCares Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 107. UCBCares Recent Development
Table 108. Aier Eye Hospital Company Detail
Table 109. Aier Eye Hospital Business Overview
Table 110. Aier Eye Hospital Retinal Disorders Therapy Product
Table 111. Aier Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 112. Aier Eye Hospital Recent Development
Table 113. Alcon Holdings, Inc. Company Detail
Table 114. Alcon Holdings, Inc. Business Overview
Table 115. Alcon Holdings, Inc. Retinal Disorders Therapy Product
Table 116. Alcon Holdings, Inc. Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 117. Alcon Holdings, Inc. Recent Development
Table 118. Eyebright Medical Company Detail
Table 119. Eyebright Medical Business Overview
Table 120. Eyebright Medical Retinal Disorders Therapy Product
Table 121. Eyebright Medical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 122. Eyebright Medical Recent Development
Table 123. Kanghong Pharmaceutical Company Detail
Table 124. Kanghong Pharmaceutical Business Overview
Table 125. Kanghong Pharmaceutical Retinal Disorders Therapy Product
Table 126. Kanghong Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 127. Kanghong Pharmaceutical Recent Development
Table 128. Huaxia Eye Hospital Company Detail
Table 129. Huaxia Eye Hospital Business Overview
Table 130. Huaxia Eye Hospital Retinal Disorders Therapy Product
Table 131. Huaxia Eye Hospital Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 132. Huaxia Eye Hospital Recent Development
Table 133. Xingqi Pharmaceutical Company Detail
Table 134. Xingqi Pharmaceutical Business Overview
Table 135. Xingqi Pharmaceutical Retinal Disorders Therapy Product
Table 136. Xingqi Pharmaceutical Revenue in Retinal Disorders Therapy Business (2018-2024) & (US$ Million)
Table 137. Xingqi Pharmaceutical Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorders Therapy Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Retinal Disorders Therapy Market Share by Type: 2022 VS 2029
Figure 3. Age Related Macular Degeneration Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Ocular Inflammatory Disease (Uveitis) Features
Figure 6. Macular Hole Features
Figure 7. Global Retinal Disorders Therapy Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 8. Global Retinal Disorders Therapy Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Retinal Disorders Therapy Report Years Considered
Figure 13. Global Retinal Disorders Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Retinal Disorders Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Retinal Disorders Therapy Market Share by Region: 2022 VS 2029
Figure 16. Global Retinal Disorders Therapy Market Share by Players in 2022
Figure 17. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Disorders Therapy as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Retinal Disorders Therapy Revenue in 2022
Figure 19. North America Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 21. United States Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 25. Germany Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Retinal Disorders Therapy Market Share by Region (2018-2029)
Figure 33. China Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 41. Mexico Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Retinal Disorders Therapy Market Share by Country (2018-2029)
Figure 45. Turkey Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Retinal Disorders Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. ALLERGAN Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 48. AbbVie Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 49. Alimera Sciences Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 50. Janssen Biotech Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 51. Swedish Orphan Biovitrum Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 52. Roche Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 54. Genzyme Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 55. Genentech Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 56. OCULAR THERAPEUTIX Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 57. Bausch & Lomb Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 58. UCBCares Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 59. Aier Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 60. Alcon Holdings, Inc. Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 61. Eyebright Medical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 62. Kanghong Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 63. Huaxia Eye Hospital Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 64. Xingqi Pharmaceutical Revenue Growth Rate in Retinal Disorders Therapy Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed